Literature DB >> 19241061

Anxiolytic effects of nicotine in a rodent test of approach-avoidance conflict.

Ami Cohen1, Robert W Young, Miguel A Velazquez, Mariya Groysman, Kavon Noorbehesht, Osnat M Ben-Shahar, Aaron Ettenberg.   

Abstract

RATIONALE: Nicotine has been reported to produce both anxiolytic and/or anxiogenic effects in humans and animals.
OBJECTIVES: This study examined whether pretreatment with nicotine would alter anxiety in a unique runway model of approach-avoidance conflict.
MATERIALS AND METHODS: Food-restricted rats were trained to run a straight alley once a day to obtain food upon goal-box entry. Beginning on trial 11, food reward was followed by a series of five foot shocks (0.3-0.4 mA, 0.5 s) in the goal box. Non-shocked control rats continued to run for food only. The resulting association of the goal box with both a positive (food) and negative (foot shock) stimulus produced an approach-avoidance conflict (subjects exhibited "retreat behaviors" in which they would approach the goal box, stop, and then retreat back towards the start box). Once retreats were established, their sensitivity to nicotine pretreatment (0.0, 0.03, 0.045, 0.06, or 0.075 mg/kg, i.v.) was compared to saline. In subsequent tests, the effects of nicotine (0.06 or 0.03 mg/kg) were examined on spontaneous activity (locomotion) and center-square entries in an open field (anxiety).
RESULTS: Doses of 0.06 and 0.075 mg/kg, but not lower doses of nicotine, reduced the number of runway retreats, and 0.06 mg/kg nicotine increased the number of open-field center entries relative to saline. No effects on locomotion were observed.
CONCLUSIONS: Nicotine reduced approach-avoidance conflict and increased the rats' willingness to enter the center of an open field, suggesting that the drug can produce anxiolytic properties and that such effects may serve as an important factor in the persistence of smoking behavior.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19241061      PMCID: PMC2920299          DOI: 10.1007/s00213-009-1486-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  73 in total

Review 1.  Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking.

Authors:  Jon D Kassel; Laura R Stroud; Carol A Paronis
Journal:  Psychol Bull       Date:  2003-03       Impact factor: 17.737

Review 2.  Cigarette-derived nicotine is not a medicine.

Authors:  Andrew C Parrott
Journal:  World J Biol Psychiatry       Date:  2003-04       Impact factor: 4.132

3.  Heroin attenuates the negative consequences of cocaine in a runway model of self-administration.

Authors:  Daniel Guzman; Aaron Ettenberg
Journal:  Pharmacol Biochem Behav       Date:  2004-10       Impact factor: 3.533

4.  Lobeline attenuates locomotor stimulation induced by repeated nicotine administration in rats.

Authors:  Dennis K Miller; Steven B Harrod; Thomas A Green; Mei-Yee Wong; Michael T Bardo; Linda P Dwoskin
Journal:  Pharmacol Biochem Behav       Date:  2003-01       Impact factor: 3.533

5.  The effects of nicotine on punished behaviour.

Authors:  C F Morrison
Journal:  Psychopharmacologia       Date:  1969

Review 6.  The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review.

Authors:  Laetitia Prut; Catherine Belzung
Journal:  Eur J Pharmacol       Date:  2003-02-28       Impact factor: 4.432

Review 7.  The Vogel conflict test: procedural aspects, gamma-aminobutyric acid, glutamate and monoamines.

Authors:  Mark J Millan; Mauricette Brocco
Journal:  Eur J Pharmacol       Date:  2003-02-28       Impact factor: 4.432

8.  Sex differences and repeated intravenous nicotine: behavioral sensitization and dopamine receptors.

Authors:  Steven B Harrod; Charles F Mactutus; Klark Bennett; Ulla Hasselrot; Guanghan Wu; Marion Welch; Rosemarie M Booze
Journal:  Pharmacol Biochem Behav       Date:  2004-07       Impact factor: 3.533

Review 9.  Motivational influences on cigarette smoking.

Authors:  Timothy B Baker; Thomas H Brandon; Laurie Chassin
Journal:  Annu Rev Psychol       Date:  2004       Impact factor: 24.137

10.  Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking.

Authors:  Michela Tessari; Maria Pilla; Michela Andreoli; Daniel M Hutcheson; Christian A Heidbreder
Journal:  Eur J Pharmacol       Date:  2004-09-19       Impact factor: 4.432

View more
  18 in total

1.  A lack of association between severity of nicotine withdrawal and individual differences in compensatory nicotine self-administration in rats.

Authors:  Andrew C Harris; Paul R Pentel; Danielle Burroughs; Mylissa D Staley; Mark G Lesage
Journal:  Psychopharmacology (Berl)       Date:  2011-04-15       Impact factor: 4.530

2.  α7-Containing nicotinic acetylcholine receptors on interneurons of the basolateral amygdala and their role in the regulation of the network excitability.

Authors:  Volodymyr I Pidoplichko; Eric M Prager; Vassiliki Aroniadou-Anderjaska; Maria F M Braga
Journal:  J Neurophysiol       Date:  2013-09-04       Impact factor: 2.714

3.  Locomotor activity does not predict individual differences in morphine self-administration in rats.

Authors:  Yayi Swain; Peter Muelken; Mark G LeSage; Jonathan C Gewirtz; Andrew C Harris
Journal:  Pharmacol Biochem Behav       Date:  2018-02-02       Impact factor: 3.533

4.  Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.

Authors:  Jill R Turner; Laura M Castellano; Julie A Blendy
Journal:  J Pharmacol Exp Ther       Date:  2010-04-30       Impact factor: 4.030

5.  Effects of lidocaine-induced inactivation of the bed nucleus of the stria terminalis, the central or the basolateral nucleus of the amygdala on the opponent-process actions of self-administered cocaine in rats.

Authors:  Jennifer M Wenzel; Stephanie A Waldroup; Zachary M Haber; Zu-In Su; Osnat Ben-Shahar; Aaron Ettenberg
Journal:  Psychopharmacology (Berl)       Date:  2011-04-13       Impact factor: 4.530

6.  Rapid well-plate assays for motor and social behaviors in larval zebrafish.

Authors:  Qiaosen Shen; Lisa Truong; Michael T Simonich; Changjiang Huang; Robyn L Tanguay; Qiaoxiang Dong
Journal:  Behav Brain Res       Date:  2020-05-16       Impact factor: 3.332

Review 7.  Cognitive enhancers for facilitating drug cue extinction: insights from animal models.

Authors:  Bríd Áine Nic Dhonnchadha; Kathleen M Kantak
Journal:  Pharmacol Biochem Behav       Date:  2011-02-02       Impact factor: 3.533

8.  Inactivation of the dorsal raphé nucleus reduces the anxiogenic response of rats running an alley for intravenous cocaine.

Authors:  Aaron Ettenberg; Oren A Ofer; Carl L Mueller; Stephanie Waldroup; Ami Cohen; Osnat Ben-Shahar
Journal:  Pharmacol Biochem Behav       Date:  2010-11-23       Impact factor: 3.533

9.  Imbalance of approach and avoidance: the yin and yang of anxiety disorders.

Authors:  Murray B Stein; Martin P Paulus
Journal:  Biol Psychiatry       Date:  2009-12-15       Impact factor: 13.382

10.  Noradrenergic β-receptor antagonism within the central nucleus of the amygdala or bed nucleus of the stria terminalis attenuates the negative/anxiogenic effects of cocaine.

Authors:  Jennifer M Wenzel; Samuel W Cotten; Hiram M Dominguez; Jennifer E Lane; Kerisa Shelton; Zu-In Su; Aaron Ettenberg
Journal:  J Neurosci       Date:  2014-03-05       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.